Stockchase Opinions

Jim Cramer - Mad Money Marvell Technology Group MRVL-Q BUY ON WEAKNESS Jan 15, 2021

An essential 5G play Many chipmakers to choose from, but Marvell is the best 5G play here. The only problem is a supply shortage due to high demand.They make chips and are a 5G play. Has a partnership wtih MSFT to make in-house server chips. Shares are trading at nosebleed levels now, though.

$50.770

Stock price when the opinion was issued

electrical electronic
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WATCH

As with other semiconductors, has really tumbled in last few months. Possibility of a bounce here. Old resistance was $75, and would look pretty good if it can break through that. So watch for that $75; if it breaks through and particularly with volumes picking up, that would be encouraging.

PARTIAL BUY

Is in the middle of an historic decline, despite its earnings having an historic advance. It's been punished enough. Buy a quarter position here and another at $50. The CEO bought a ton of stock.

BUY

They are doing everything right, but face very good competition. This gets no credit in data centres.

PAST TOP PICK
(A Top Pick Apr 24/24, Down 14%)

A year ago, everyone was trying to find the next best thing to NVDA. System-on-a-chip puts chips out closer to the data, a nice niche. 12-month price target of $112.50, great runway.

DON'T BUY

Semiconductors, broadly, have become like shooting fish in a barrel since ChapGPT made its debut in late 2022. All are pretty cyclical. Likes others better, such as NVDA and AVGO.

DON'T BUY

Interesting company. Big issue on semi demand is really the Chip Act, how it applies to China, and what it does to demand for everyone else. China will be looking to increase market share. You want bigger and better, so he'd probably rather own AVGO.

BUY ON WEAKNESS

Good to buy at current levels. They last delivered a good quarter apart from one glitch with a customer.

BUY

The market didn't like their quarter and sold it, but it's wrong. He likes that the stock bounced at $60 and is up to $71 today.

BUY

He targets $108. They just beat top and bottom lines and raised guidance. They delivered record Q1 revenue, a 63% pop YOY. Are running on all cylinders. Strong momentum.

DON'T BUY

Doesn't own because of the cyclical industry. If you get the timing right, can do very well. He likes companies with an economic moat such as TSM, and he's considering ASML.